Hubei Guangji Pharmaceutical Co., Ltd.

000952

CNE0000010R5

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
5.78 ^CNY	+0.87%		-3.99%	-27.66%

25/04	Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
25/04	Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Hubei Guangji Pharmaceutical Co., Ltd. Announces Cash Dividend on A Shares for the Year 2021, Payable on May 27, 2022

May 20, 2022 at 01:07 am IST

Hubei Guangji Pharmaceutical Co., Ltd. announced cash dividend on A shares (tax included) of CNY 0.6000000 per 10 shares for the year 2021. Record date is May 26, 2022. Ex-date is May 27, 2022.

The dividend will be payable on May 27, 2022.

Latest news about Hubei Guangji Pharmaceutical Co., Ltd.

Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	25/04	CI
Guangji Pharmaceutical Gets Nod to Produce Entecavir	07/11	MT
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	20/23/20	CI
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	30/23/30	CI
Guangji Pharma to Establish Joint Innovation Laboratory With Jiangnan University	15/23/15	MT
Guangji Pharma to Borrow 281 Million Yuan From Bank to Support Acquisition Deals	17/23/17	MT
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/23/27	CI
Hubei Guangji Pharmaceutical Announces Profit Distribution Proposal for 2022	21/23/21	CI
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	19/23/19	CI
Guangji Pharma Registers Diabetes-Related Infection Drug	29/23/29	MT
Hubei Guangji Pharma to Invest 468 Million Yuan in Parkson Biotechnology Amid Bankruptcy Reorganization	08/23/08	MT
Hubei Guangji Pharma Signs 6MW Solar Power Project	15/22/15	MT
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/22/27	CI
Guangji Pharmaceutical Unit to Resume Production After Three-Month Stoppage	04/22/04	MT
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	18/22/18	CI
Hubei Guangji Pharmaceutical Jikang Medicine Co., Ltd. announced that it has received CNY 45 million in funding from Hubei Guangji Pharmaceutical Co., Ltd.	19/22/19	CI
Hubei Guangji Pharmaceutical Co., Ltd. Announces Cash Dividend on A Shares for the Year 2021, Payable on May 27, 2022	20/22/20	CI
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/22/28	CI
Hubei Guangji Pharmaceutical Co., Ltd. Approves Cash Dividend for 2021	22/22/22	CI
Hubei Guangji Pharmaceutical Co., Ltd. Announces the Profit Distribution Proposal for the Year 2021	26/22/26	CI
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	24/22/24	CI
Guangji Pharmaceutical Co. Ltd. announced that it has received CNY 180 million in funding from Hubei Guangji Pharmaceutical Co., Ltd.	02/21/02	CI
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	22/21/22	CI
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	18/21/18	CI

Chart Hubei Guangji Pharmaceutical Co., Ltd.

Duration

Period

Chart Hubei Guangji Pharmaceutical Co., Ltd.

More charts

Hubei Guangji Pharmaceutical Co., Ltd. is the Chinese leader of pharmaceutical ingredients production. The group's activity is organized around four product families: - vitamins: riboflavin and beta carotene; - food supplements; - fine chemistry products; - medicinal preparations.

Sector

Pharmaceuticals

Calendar

19/06/2024 - Extraordinary Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
HUBEI GUANGJI PHARMACEUTICAL CO., LTD.	-27.66%	28Cr
ELI LILLY AND COMPANY	+40.73%	74TCr
NOVO NORDISK A/S	+32.83%	60TCr
JOHNSON & JOHNSON	-6.30%	35TCr
MERCK & CO., INC.	+15.15%	32TCr
ABBVIE INC.	+4.05%	28TCr
ASTRAZENECA PLC	+15.00%	24TCr
NOVARTIS AG	+9.78%	21TCr
ROCHE HOLDING AG	-5.52%	21TCr
AMGEN INC.	+6.17%	16TCr

Other Pharmaceuticals